Research Funding

May 3, 2017

Lichen sclerosus (LS) is a chronic, lymphocyte mediated cutaneous disorder affecting approximately one in seventy women. Presenting symptoms may include intense pruritis, pain, burning, and dyspareunia.  This disorder may affect any area of the skin, but has a notable predilection for the female genital region, in particular, the vulva, per anal area and the groin. Affected females outnumber affected males by 13:1. The purpose of the study is to determine the differences in the genomic/proteomic/glycomic profiles between lichen sclerosus (LS) and non-vulvar skin (with no LS clinically) for women with vulvar lichen sclerosus. The goal is to identify and validate biomarkers for Lichen Sclerosus and find the most effective cure for it. View Award Letter >>